Viewing StudyNCT00038532



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00038532
Status: COMPLETED
Last Update Posted: 2008-04-01
First Post: 2002-05-31

Brief Title: AmprenavirRitonavir SaquinavirRitonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra ABT-378Ritonavir as Their First Protease Inhibitor Based HAART
Sponsor:
Organization: Abbott